Skip to content

Enzalutamide

Enzalutamide, sold under the brand Xtandi, is a medicine used in the treatment of prostate cancer. This page lists the one formulation available in this catalogue.

Xtandi

Prostate Cancer

40mg

Enzalutamide capsules for prostate cancer. They block male hormones like testosterone from helping cancer grow.

From$19.02/ capsuleView

Key points

  • Enzalutamide is an androgen receptor inhibitor that blocks male hormones from reaching prostate cancer cells.
  • The listed Xtandi capsule comes in a 40mg strength.
  • It is used for advanced prostate cancer, including when the disease has spread or returned after prior therapy.

Common questions about Enzalutamide

What is Xtandi?

Xtandi is the originator brand name for enzalutamide, marketed by Astellas Pharma Europe B.V. It is listed in this catalogue as a 40mg capsule for advanced prostate cancer.

Is there more than one form available?

No. This catalogue lists only the 40mg capsule form of enzalutamide.

Further reading